Instrument Inactif

Communiqués CONN ALPH Nasdaq

Actions

Communiqués

05/08/20	DermTech, Inc. : Reports Second Quarter 2020 Financial Results and Provides Corporate Update	BU
30/06/20	CONN ALPH : DermTech Announces Inclusion in the Russell 2000 Index	BU
20/05/20	CONN ALPH : DermTech PLA Included in Peer Review Article of Novel Molecular Technologies for Melanoma Management with Potential to Address Current Gaps in Diagnostic Accuracy and Prognostication	BU
13/05/20	DermTech, Inc. : Reports First Quarter 2020 Financial Results and Provides Corporate Update	BU
11/05/20	CONN ALPH : Proof-of-Concept Research Demonstrates Patients Reliably Perform Remote Self-Sampling of Concerning Moles Using DermTech’s Non-Invasive Adhesive Skin Collection Kit Under Physician Supervision via Telemedicine	BU
05/05/20	CONN ALPH : The Melanoma Research Foundation Hosting Weekly Facebook Live ‘Ask a Dermatologist’ Sessions throughout Melanoma Awareness Month	BU
30/04/20	CONN ALPH : DermTech Announces Telemedicine Solution to Enable Remote Use of its Non-Invasive Adhesive Patch Test for Melanoma Detection	BU
25/03/20	CONN ALPH : DermTech Announces Response to COVID-19	BU
16/03/20	CONN ALPH : New Study Shows Combining TERT Mutation Analyses With DermTech’s PLA Provides Improved Sensitivity for Detecting Melanoma With Non-invasive Patches	BU
10/03/20	DermTech, Inc. : Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update	BU
05/03/20	CONN ALPH : Large Registry Study Demonstrates Clinicians Use DermTech’s Non-Invasive Gene Expression Testing to Improve Early Melanoma Detection	BU
03/03/20	CONN ALPH : DermTech to Participate at the 2020 BTIG Healthcare Conference	BU
02/03/20	CONN ALPH : DermTech Announces $65 Million Private Placement	BU
11/02/20	CONN ALPH : DermTech to Present at Upcoming Investor Conferences	BU
16/01/20	CONN ALPH : DermTech Enters into Commercial and Medicare Advantage Payor Coverage Contract for the Pigmented Lesion Assay	BU
08/01/20	CONN ALPH : CMS Releases Final 2020 Clinical Lab Fee Schedule (CLFS) Including Pricing for DermTech’s Pigmented Lesion Assay (PLA)	BU
02/01/20	CONN ALPH : DermTech’s Pigmented Lesion Assay (PLA) Receives Medicare Coverage	BU
07/11/19	DermTech, Inc. : Reports Third Quarter 2019 Financial Results and Provides Corporate Update	BU
06/11/19	CONN ALPH : DermTech to Present at Upcoming Investor Conferences	BU
28/10/19	CONN ALPH : DermTech Receives CPT® Proprietary Laboratory Assay Code from the American Medical Association	BU
22/10/19	DermTech : Presents New Data at Fall Clinical Dermatology Conference	BU
18/10/19	CONN ALPH : DermTech Announces Common Stock Will Continue Trading on The Nasdaq Capital Market; Warrant Delisting from The Nasdaq Capital Market	BU
15/10/19	CONN ALPH : DermTech’s Test Included in Expert Panel’s Clinical Management Recommendations for Cutaneous Melanoma	BU
07/10/19	CONN ALPH : DermTech Further Expands Patent Portfolio	BU
16/09/19	CONN ALPH : DermTech Announces Appointment of Kevin Sun as Chief Financial Officer	BU